精神分裂症GABA-A受体差异:[11C]Ro154513正电子发射断层成像研究
未用药患者海马VT显著低于对照,且VT与PANSS总分正相关;用药患者与对照无显著差异。结果提示未用药精神分裂症患者海马α5-GABAAR水平降低,支持GABA功能低下假说。
要点
- 未用药精神分裂症患者海马[11C]Ro15-4513 VT显著低于健康对照(p<0.05,效应量1.4)。
- 未用药患者海马VT与PANSS总分呈显著正相关(r=0.72;p=0.044)。
- 用药患者海马VT与对照无显著差异(p=0.64)。
核心结论
- 未用药精神分裂症患者海马α5-GABAAR水平降低,支持GABA功能低下参与该病病理生理的假说。
- 海马α5-GABAAR可用性与未用药患者症状严重程度(PANSS总分)呈正相关。
研究设计与样本
- 所有受试者接受[11C]Ro15-4513 PET扫描和MRI,动态PET数据用双组织 compartment 模型和动脉血浆输入函数分析,以总分布容积VT为结局指标。
- 症状严重程度用PANSS量表评估。
主要发现
- 未用药患者海马[11C]Ro15-4513 VT显著低于健康对照(p<0.05;效应量=1.4)。
- 用药患者海马[11C]Ro15-4513 VT与健康对照无显著差异(p=0.64)。
- 未用药患者海马[11C]Ro15-4513 VT与PANSS总分呈显著正相关(r=0.72;p=0.044)。
临床怎么用
- 提示海马α5-GABAAR可用性降低可能是未用药精神分裂症患者的在体病理特征,GABA-A受体靶向PET可为机制研究和药物开发提供参考。
- α5-GABAAR可用性与PANSS总分的正相关提示其可能与症状严重程度相关,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A loss of GABA signaling is a prevailing hypothesis for the pathogenesis of schizophrenia. Preclinical studies indicate that blockade of the α5 subtype of the GABA receptor (α5-GABAARs) leads to behavioral phenotypes associated with schizophrenia, and postmortem evidence indicates lower hippocampal α5-GABAARs protein and mRNA levels in schizophrenia. However, it is unclear if α5-GABAARs are altered in vivo or related to symptoms. We investigated α5-GABAARs availability in antipsychotic-free schizophrenia patients and antipsychotic-medicated schizophrenia patients using [11C]Ro15-4513 PET imaging in a cross-sectional, case-control study design. Thirty-one schizophrenia patients (n = 10 antipsychotic free) and twenty-nine matched healthy controls underwent a [11C]Ro15-4513 PET scan and MRI. The α5 subtype GABA-A receptor availability was indexed using [11C]Ro15-4513 PET imaging. Dynamic PET data were analyzed using the two-tissue compartment model with an arterial plasma input function and total volume of distribution (VT) as the outcome measure. Symptom severity was assessed using the PANSS scale. There was significantly lower [11C]Ro15-4513 VT in the hippocampus of antipsychotic-free patients, but not in medicated patients (p = 0.64), relative to healthy controls (p < 0.05; effect size = 1.4). There was also a significant positive correlation between [11C]Ro15-4513 VT and total PANSS score in antipsychotic-free patients (r = 0.72; p = 0.044). The results suggest that antipsychotic-free patients with schizophrenia have lower α5-GABAARs levels in the hippocampus, consistent with the hypothesis that GABA hypofunction underlies the pathophysiology of the disorder.
引用
- Marques TR, Ashok AH, Angelescu I, et al. GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513. Mol Psychiatry. 2020. PMID: 32296127. doi:10.1038/s41380-020-0711-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。